Advertisement

Related Videos

Victoria T. Brown, PharmD, BCOP, on Payer Intervention: The Example of Abiraterone

David A. Hyman, MD, JD, on Inclusive Shared Savings

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Blase Polite, MD, MPP, FASCO, on Transforming the Drug Cost Curve in the United States: Not How But If

Advertisement

Advertisement




Jan
09
Today In Oncology
ACS Guidelines for Cervical Cancer Self-Collected HPV Testing Now Included
Early Results Show Pirtobrutinib Matches Ibrutinib in BTK Inhibitor-Naive CLL
Prostate Cancer: Novel PSMA-Targeted Radioligand Shows Reduced Salivary Gland Uptake in Preclinical Studies
CD123-Targeting ADC Shows Activity in AML and BPDCN
New Pooled Analysis Strengthens Case for MRD as Surrogate Endpoint in AML
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo